ConductScience.org, home

Paper6961973

Role of the host in the variable chemotherapeutic response of advanced Ridgway osteogenic sarcoma.

Nelson JA and 2 others. Cancer Chemother Pharmacol, 1982. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Role of the host in the variable chemotherapeutic response of advanced Ridgway osteogenic sarcoma. Papers, record 6961973. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6961973

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Role of the host in the variable chemotherapeutic response of advanced Ridgway osteogenic sarcoma.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1982
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.49
iCite
Revised in PubMed
2026-10-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nelson JAJ A
2Hokanson JAJ A
3Jenkins VKV K

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MelphalanMajor topic
OsteosarcomaMajor topic
VincristineMajor topic
Analysis of Variance
Animals
Dose-Response Relationship, Drug
Male
Mice
Mice, Inbred AKR
Neoplasm Transplantation
Sarcoma, Experimental

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA-16672NCI NIH HHSUnited StatesP01CA016672PubMed and NIHNIH RePORTER
CA-28034NCI NIH HHSUnited StatesR01CA028034PubMed and NIHNIH RePORTER
P30CA016672NIHNIH RePORTER

Download CSV of grants

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17044517Favorable factors in the adjuvant therapy of breast cancer.Cancer1982https://conductscience.org/library/papers/7044517PubMed
24499910Combination chemotherapy for spontaneous AKR lymphoma.Cancer Chemother Rep 21974https://conductscience.org/library/papers/4499910PubMed
37248979Biological and experimental consequences of the zonal composition of solid tumors.Cancer Res1981https://conductscience.org/library/papers/7248979PubMed
41260756Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.Cancer Res1976https://conductscience.org/library/papers/1260756PubMed
514221786PERSPECTIVES IN CANCER CHEMOTHERAPY: THERAPEUTIC DESIGN.Cancer Res1964https://conductscience.org/library/papers/14221786PubMed
64644205Differential sensitivites of human melanoma cells grown in vitro to arabinosylcytosine.Cancer Res1972https://conductscience.org/library/papers/4644205PubMed
7710805Mechanism of natural resistance of rat ascites hepatomas to 1-beta-D-arabinofuranosylcytosine.Gan1978https://conductscience.org/library/papers/710805PubMed
87390894Concurrent and subsequent tumors in the same host: a model to evaluate the host tumor interaction.Int J Radiat Oncol Biol Phys1980https://conductscience.org/library/papers/7390894PubMed
96947891Concepts for controlling drug-resistant tumor cells.Eur J Cancer (1965)1980https://conductscience.org/library/papers/6947891PubMed
10354778Tumor heterogeneity and the biology of cancer invasion and metastasis.Cancer Res1978https://conductscience.org/library/papers/354778PubMed
114827349On the presence within tumours of clones that differ in sensitivity to cytostatic drugs.Acta Pathol Microbiol Scand A1974https://conductscience.org/library/papers/4827349PubMed
126961973Role of the host in the variable chemotherapeutic response of advanced Ridgway osteogenic sarcoma.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6961973PubMed
13698935Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor.Cancer Res1978https://conductscience.org/library/papers/698935PubMed
145670719Success and failure in the treatment of solid tumors. I. Effects of cyclophosphamide (NSC-26271) on primary and metastatic plasmacytoma in the hamster.Cancer Chemother Rep1968https://conductscience.org/library/papers/5670719PubMed
156994913The practical benefits of pharmacokinetics in the use of antineoplastic agents.Cancer Chemother Pharmacol1980https://conductscience.org/library/papers/6994913PubMed

Download CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
15256002The influence of tumor size and environment on gene expression in commonly used human tumor lines.BMC Cancer2004https://conductscience.org/library/papers/15256002PubMed
6961973Role of the host in the variable chemotherapeutic response of advanced Ridgway osteogenic sarcoma.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6961973PubMed
3690803Variability of tumor response to chemotherapy. I. Contribution of host heterogeneity.Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3690803PubMed
3470163Changing metastatic patterns of a transplantable rat osteosarcoma.Clin Exp Metastasis1987https://conductscience.org/library/papers/3470163PubMed
3409443Variability of tumor response to chemotherapy. II. Contribution of tumor heterogeneity.Cancer Chemother Pharmacol1988https://conductscience.org/library/papers/3409443PubMed
1568290Mechanisms of resistance to 6-thioguanine in a murine pancreatic tumor.Cancer Chemother Pharmacol1992https://conductscience.org/library/papers/1568290PubMed
1348974Intrinsic resistance to anticancer agents in the murine pancreatic adenocarcinoma PANC02.Cancer Chemother Pharmacol1992https://conductscience.org/library/papers/1348974PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6961973

GET https://conductscience.org/api/papers/v1/6961973/authors